If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
In this month’s skin cancer update, Professor Giuseppe Argenziano discusses facial and non-facial lentiginous melanoma featuring real-life cases and some of his very own scholarly articles. Professor Argenziano draws on his previous research of lentiginous melanoma as a “newly defined entity”, and explores what you need to know about the special type of melanoma from a biological point of view.
New online melanoma risk calculators help predict melanoma risk and potentially deadly spread.
Clinicians and their patients now have access to a series of online calculators which will assist in prevention, early detection and optimum treatment of melanoma, ultimately saving lives. Continue reading “[1 min read] New online melanoma risk calculators”
Treating actinic keratosis is very common in general practice, and especially so in primary care skin cancer medicine. Many patients require treatment of both individual lesions (for example, by cryotherapy) and of the whole field that is affected (for example, the whole face, using a topical treatment, or a field treatment more generally). Continue reading “[2 min read] Field treatments for actinic keratosis | Prof David Wilkinson”
How effective and safe is photodynamic therapy in treating Bowen’s disease? Bowen’s disease is an intraepidermal squamous cell carcinoma (SCC). There are several alternatives for treatment of Bowen’s disease, including photodynamic therapy. A new study investigated the efficacy and safety of photodynamic therapy in treating the skin condition. Continue reading “[3 min read] Photodynamic therapy for Bowen’s disease”
In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses re-excising skin lesions for which the histopathology results are unclear. Using real-life cases, Giuseppe explores what you should do when malignancies recur in sites where previous malignancies were excised, and how to manage these patients. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2020]”
In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about the three possible outcomes that can be reached after you check a lesion: Excise, monitor, or do nothing. In most cases, lesions are either deemed suspicious and excised, or deemed safe and the patient goes home. Giuseppe warns that the other option – monitoring the lesion at follow-up appointments – should be used with caution and in limited cases. He goes through the scenarios in which monitoring the lesion is a good choice and how doctors can go about the follow-up procedure. Continue reading “[5 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2020]”
Sun damage is a common skin concern seen in primary care – from sunburns to pigmentation, sun spots, wrinkles and skin cancers. Research Review‘s latest educational series focuses on sunscreen and photoageing, with expert commentary by dermatologists. It explores the mechanisms of skin photoageing and the role of sunscreen as an adjunctive sun protection measure in the prevention of photoaeging. Continue reading “[2 min read] How does sunscreen prevent photoageing?”
Is psoriasis or psoriatic arthritis associated with an increased risk of cancer? A recent review looked at the association and risk of cancer in patients with these conditions. Continue reading “[2 min read] Is psoriasis associated with increased risk of skin cancer?”
Non-melanoma skin cancer is the most commonly diagnosed cancer in Australia, with around 800,000 confirmed cases each year. General practitioners alone have over one million skin cancer-related consultations annually, with lesion diagnosis being among patients’ most common skin concerns in primary care.
The two main types of non-melanoma skin cancer are: Continue reading “[3 min read] 5 common treatments for non-melanoma skin cancer”
In this month’s skin cancer update video, Professor Giuseppe Argenziano explores concepts around congenital naevi, in the last of a two-part series. He discusses how, if there is any precursor to melanoma, congenital naevi is the most important one.